Fairvalue-Calculator Fairvalue-Calculator
EN DE

Mediana Co (041920) Fair Value & Analysis

Healthcare · KR · Market cap 248B KRW

Price12,600 KRW
Fair Value13,550 KRW
Upside+7.5%
Quality95/100
Evidence: High Range 10,162 KRW – 16,937 KRW

Fair value as of: Jun 24, 2026

Analysis

Mediana Co (041920) currently trades at 12,600 KRW, while our model-based Fair Value estimate is 13,550 KRW — implying the stock looks roughly 7.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Mediana Co.,Ltd, together with its subsidiaries, develops, manufactures, and sells medical devices in South Korea. It offers patient monitors, vital signs monitors, AEDs, monitors/defibrillators, fetal products, body composition analyzers, central monitoring systems, face masks, spot checks and monitors, pulse oximeters, and physio modules. The company also exports ODM and own branded products through agencies in approximately 80 countries. Mediana Co.,Ltd was founded in 1993 and is headquartered in Wonju-si, South Korea.

Open the full interactive analysis →

Similar stocks

InBody Co (041830) +10% i-SENS, Inc (099190) -84% Value Added Technology Co (043150) +238% Meta Biomed Co (059210) +147% Sewoon Medical Co (100700) +186% Medicon Hellas S.A (MEDIC) +5%

Frequently asked questions

Is Mediana Co (041920) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 13,550 KRW versus a price of 12,600 KRW — about +8% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 041920?
Our 21-model fair value for Mediana Co is 13,550 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 12,600 KRW.
What is the quality score of 041920?
Mediana Co has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.